Repigmentation pathways

Vitiligo Management

Vitiligo is treatable, and the field has moved quickly. Modern care combines topical immunomodulators, targeted phototherapy, and — for stable cases — surgical repigmentation. The right path depends on disease activity, location, and stability over time.

Vitiligo Management

Your decision stage

  1. 01Research
  2. 02Comparison
  3. 03Evaluation
  4. 04Decision
  5. 05Ready

What it is

In plain terms.

Vitiligo management combines topical immunomodulators, targeted phototherapy, and — for stable disease — surgical repigmentation, all sequenced by disease activity and stability.

Who it is for

  • 01Newly diagnosed patients seeking the right first step
  • 02Patients with stable disease considering surgical options
  • 03People who have tried single-modality treatment without progress

What to know first

01

Disease activity must be assessed before any intervention

02

Phototherapy outcomes are cumulative and require consistency

03

Surgical options apply only to stable, non-progressing patches

Benefits

What patients gain.

Modern protocols achieve meaningful repigmentation

Combination therapy outperforms isolated approaches

Stabilisation reduces the anxiety of unpredictable spread

Protocols

Approaches, considered.

Topical therapy

Calcineurin inhibitors and newer JAK pathway options.

Phototherapy

Narrowband UVB and targeted excimer protocols.

Surgical repigmentation

Melanocyte transfer and punch grafting for stable disease.

Compare

Compare treatment paths.

Common modalities considered within vitiligo management. Each has different candidacy, recovery, and long-term economics — use this as the shortlist to bring into a consultation.

01

Medical Therapy

02

Phototherapy

03

Surgical Options

04

Regenerative Approaches

Honest comparison

Pros & considerations.

Pros

  • +Evidence-based pathways exist for most cases
  • +Surgical options are durable for the right candidates
  • +Newer JAK pathway options expanding the toolkit

Considerations

  • Repigmentation is gradual and not always complete
  • Surgical options only apply to stable disease
  • Consistency is the largest predictor of phototherapy success

Cost

₹5,000 – ₹2,00,000

Phototherapy is per-session and cumulative. Surgical repigmentation is priced by area treated.

Recovery

Topical and phototherapy have no downtime. Surgical grafting requires 1–2 weeks of healing per treated area.

Alternatives

Adjacent paths worth knowing.

01

Camouflage and corrective cosmetics

02

Counselling-led acceptance pathways

03

Watchful monitoring for very early presentations

FAQs

Questions, answered.

Is vitiligo curable?

+

Vitiligo is treatable, not curable. Modern combination therapy achieves meaningful repigmentation for most patients, especially when started early and sustained consistently.

How do I know if vitiligo management is right for me?

+

The honest answer requires a clinical consultation. Use this guide to build the questions you bring to that conversation — candidacy depends on your goals, medical history, expectations, and the realistic outcomes for your specific case.

How long until I see results?

+

Timelines vary by protocol. Most clinical pathways show partial change in 8–12 weeks and full results in 6–12 months. Be cautious of anyone promising faster.

Will I need maintenance?

+

Almost every aesthetic protocol requires maintenance. Ask any provider for their long-term plan — and the projected cost over five years, not just the first session.

Quick answer

Vitiligo management combines topical immunomodulators, narrowband UVB or targeted excimer phototherapy, and — for stable disease — surgical repigmentation. The right path depends on disease activity, location, and stability over time.

Key takeaways

  • 01Disease activity must be assessed before any intervention
  • 02Phototherapy outcomes are cumulative — consistency is the largest predictor of success
  • 03Surgical options apply only to stable, non-progressing patches
  • 04Combination therapy outperforms single-modality treatment

Treatment pathway

The arc, stage by stage.

  1. 01

    Assess activity

    Disease activity score and Wood's lamp assessment first.

  2. 02

    Stabilise

    Topical and systemic options to halt spread before pigment work begins.

  3. 03

    Repigment

    Phototherapy or combination therapy across a 6–12 month horizon.

  4. 04

    Surgical (if stable)

    Melanocyte transfer for patches stable for 12+ months.

Candidate framework

Who this is — and isn't — for.

Ideal candidates

  • +Newly diagnosed patients seeking the right first step
  • +Stable disease considering surgical options
  • +Patients who can sustain a twice-weekly phototherapy cadence

Not ideal

  • Actively spreading disease — stabilise first
  • Patients unable to commit to multi-month phototherapy
  • Surgical candidacy with disease activity in the past 12 months

Alternatives

  • ·Camouflage and corrective cosmetics
  • ·Counselling-led acceptance pathways
  • ·Watchful monitoring for very early presentations

Comparison intelligence

Approaches, side by side.

ApproachDowntimeCadenceCost band
Topical therapyNoneDaily₹1,500–₹6,000 / month
PhototherapyNone2–3× weekly₹500–₹2,000 / session
Surgical repigmentation1–2 weeksPer area₹15,000–₹80,000 / area

Cost intelligence

What actually drives the price.

  • 01Phototherapy session count (typically 60–120 sessions for meaningful response)
  • 02Topical brand vs generic
  • 03Surgical area treated
  • 04Combination protocol depth

Recovery expectations

Topical and phototherapy have no downtime. Surgical grafting needs 1–2 weeks of healing per treated area.

Decision checklist

Before you commit, verify every one.

  • Topical therapy. Calcineurin inhibitors and newer JAK pathway options.
  • Phototherapy. Narrowband UVB or targeted excimer — twice weekly, sustained.
  • Surgical repigmentation. Melanocyte transfer or punch grafting for stable disease.

Questions to ask in consultation

The questions that protect your outcome.

  • Q1What is my current disease activity score?
  • Q2What repigmentation can I realistically expect at 12 months?
  • Q3Am I a candidate for surgical options now or later?
  • Q4What is the maintenance plan after the active phase?

Decision tool · 4 min

Vitiligo Treatment Explorer

Identify your disease activity, candidacy and the right treatment sequence.

Begin the tool →

Continue your journey

The next step, recommended.

Decision support

Is this your path?

Begin your assessment

Talk To AltisPath

Need help understanding your options?

Want personalized guidance based on your situation? Tell us about your goals — and a AltisPath advisor will help you understand options, compare approaches, and determine your next step.

Talk To AltisPath Start Assessment

Personalized · Confidential · No obligation

Explore related

You may also be interested in.

Treatment categories often connect. These pathways tend to be considered alongside vitiligo management.